Citations 3
Erenumab Immunogenicity: a Pooled Analysis of Phase 2 and Phase 3 Migraine Prevention Clinical Trials (P4.098)
Vargas, Bert B., Starling, Amaal J. , Silberstein, Stephen D., Zhou, Yanchen , Trotman, Marie‐Louise, Xue, Fei , Sahebkar-Moghaddam, Farhad, Picard, Hernàn , Mikol, Daniel D.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002)
Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)
Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available